Health
One vaccine dose is sufficient for immunity in COVID survivors, finds study – European Pharmaceutical Review
New research shows a second COVID-19 vaccine dose may not be necessary in individuals previously infected with SARS-CoV-2.
Posted: 11 March 2021 | Hannah Balfour (European Pharmaceutical Review) | No comments yet
New research shows a second COVID-19 vaccine dose may be unnecessary in individuals previously infected with SARS-CoV-2 and needlessly exposes individuals to higher rates of adverse effects.
[Credit: Dimitris Barletis/Shutterstock.com].
Researchers have found that a single dose of either the Pfizer-BioNTech Comirnaty® or Moderna mRNA-1273 COVID-19 vaccines may be sufficient to provide immunity to individuals…
Continue Reading
